Gilenya and Tascenso ODT are approved to treat relapsing forms of multiple sclerosis (MS) in adults. Gilenya and Tascenso ODT ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

Some treatments for multiple sclerosis (MS) help ease day-to-day symptoms, while others can help control an attack (relapse). Other medicines are designed to limit further damage to the nervous system ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Selma Blair is revealing her latest treatment for multiple sclerosis. “Hi. So a lot of people have been asking me how I am doing so great and my movement is so much different, and I really am excited, ...

Levels of two types of bacteria in your gut could help improve the diagnosis and treatment of multiple sclerosis. When you purchase through links on our site, we may earn an affiliate commission. Here ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...